Clinical trial
Vaccine Therapy in Treating Patients With Metastatic Melanoma
NCT00017355 · Baylor Health Care System, Other · Unknown status
Key facts
| NCT number | NCT00017355 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Metastatic Melanoma |
| Official title | Mature Dendritic Cell Immunotherapy Of Metastatic Melanoma- A Phase I Trial |
| Lead sponsor | Baylor Health Care System, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Biological |
| Interventions | filgrastim, therapeutic autologous dendritic cells |
| Start date | Apr 1, 2001 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: